SCHEMBL30630405

SCHEMBL30630405

COc1c(C#N)cccc1-c1cccnc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.47
▸ GLA P06280 3/20 0.47
▸ NPSR1 Q6W5P4 2/20 0.45
▸ RXFP1 Q9HBX9 2/20 0.45
▸ CYP11B2 P19099 3/20 0.44
▸ POLB P06746 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ SQOR Q9Y6N5 1/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ MAPK14 Q16539 1/20 0.43
▸ CYP11B1 P15538 2/20 0.42
▸ CYP17A1 P05093 1/20 0.42
▸ CYP19A1 P11511 1/20 0.42
▸ HPGD P15428 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ CLK1 P49759 1/20 0.41
▸ CYP1A2 P05177 2/20 0.40
▸ CYP3A4 P08684 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3255411 1.00 KDM4E (0.47) KDM4EGLANPSR1RXFP1CYP11B2
SCHEMBL29992603 0.85 CYP11B2 (0.41) KDM4EGLANPSR1RXFP1CYP11B2
SCHEMBL1423554 0.83 SQOR (0.46) KDM4EHTTSQORALDH1A1MAPK14
SCHEMBL16428785 0.81 MAOA (0.47) KDM4ENPSR1POLBSQORALDH1A1
SCHEMBL2146568 0.80 NISCH (0.49) KDM4EGLACYP11B2MAPK1HTT
SCHEMBL30630392 0.79 ESR2 (0.55) KDM4EGLACYP11B2ALDH1A1CYP11B1
SCHEMBL31264147 0.79 ESR2 (0.55) KDM4EGLACYP11B2ALDH1A1CYP11B1
SCHEMBL14856915 0.79 ESR2 (0.55) KDM4EGLACYP11B2ALDH1A1CYP11B1
SCHEMBL23931114 0.79 MKNK1 (0.45) CYP11B2ALDH1A1SMN1; SMN2CYP11B1CYP19A1
SCHEMBL28721464 0.78 KDM4E (0.50) KDM4EGLANPSR1RXFP1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116981669-A Pyrimidine or pyrido heterocyclic adenosine receptor inhibitor, preparation method and application thereof 上海齐鲁制药研究中心有限公司 2023-10-31 — — CN disclosed
Send feedback